Regeneron bispecific antibody targeting BCMA update | Joshua Richter, MD | ASH 2021

(1:28)

27. Regeneron Presentation with Katherine Cygnar

(12:20)

Regeneron CEO: Our antibody treatment helps immune system win battle

(4:10)

PCF Salons: The Science Behind Regeneron’s Experimental Antibody Treatment

(15:30)

A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer

(49:7)

Behind the Science: The Immuno-Oncology Revolution

(1:24)

Why Regeneron's antibody drug will be in short supply

(4:29)

Regeneron Co-Founder on Monoclonal Antibody Treatment

(18:35)

VERIFY: Regeneron treatment efficacy

(2:2)

Regeneron: The Path from Basic Research to Commercial Product

(2:2:44)

Regeneron CEO: We want to retain efficacy and eliminate bad side effects with our cancer treatments

(7:6)

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

(11:49)

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.

(56:35)

Mechanistic model-informed discovery \u0026 development of bispecific antibodies for immuno-oncology

(55:53)

If You Get COVID 19: Optimize Immune System (Vitamin D, Monoclonal Antibodies, NAC, Quercetin etc.)

(39:55)

Our Medicines

(3:29)

Know Your Myeloma Immunotherapy: Teclistamab and other Bispecifics

(58:)

Breakthrough Bispecific Antibody R\u0026D Techniques

(1:1:47)

Manufacturing of Biologics

(6:7)

Regeneron CEO on the prospects for its eye drug Eylea

(3:29)

How Biotech Company Regeneron Flipped The Script In Drug Development | IBD

(1:59)

Regeneron’s Mission

(4:51)

Checkpoint inhibitor/bispecific antibody combo: REGN2810 and REGN1979 in B-lymphoid malignancies

(1:13)

Regeneron CEO: We'll likely have to constantly adapt our antibody cocktail

(4:10)

CD20/CD3 bispecific antibodies in R/R DLBCL: glofitamab and epcoritamab

(1:21)

Regeneron's antibody drug offers strong protection against Covid-19

(2:17)

Regeneron's antibody drug reduces risk of death in some Covid patients

(2:1econd)

Regeneron's antibody drug likely to be in short supply because it's grown in live cells

(2:2)

Regeneron to ask FDA to expand EUA for antibody treatment after positive study results

(1:26)

Regeneron antibody drug shown to prevent symptomatic Covid-19

(3:16)